Who makes Cebranopadol 100 micrograms?

Cebranopadol 100 micrograms is developed by Tris Pharma, Inc..

What development phase is Cebranopadol 100 micrograms in?

Cebranopadol 100 micrograms is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Cebranopadol 100 micrograms

Tris Pharma, Inc. · Phase 1 active Small molecule

At a glance

Generic name	Cebranopadol 100 micrograms
Sponsor	Tris Pharma, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cebranopadol 100 micrograms CI brief — competitive landscape report
Cebranopadol 100 micrograms updates RSS · CI watch RSS
Tris Pharma, Inc. portfolio CI